Skip to main content
ORTHOCELL LIMITED logo

ORTHOCELL LIMITED — Investor Relations & Filings

Ticker · OCC ISIN · AU000000OCC6 ASX Manufacturing
Open in API
Filings indexed 780 across all filing types
Latest filing 2021-10-25 Share Issue/Capital Cha…
Country AU Australia
Listing ASX OCC

About ORTHOCELL LIMITED

https://orthocell.com/

Orthocell Limited is a regenerative medicine company focused on the development and commercialization of innovative technologies for the repair and regeneration of human soft tissue. The company’s core product portfolio includes the CelGro platform, a naturally derived collagen medical device designed to facilitate tissue repair and reconstruction in applications such as dental bone and soft tissue regeneration, nerve repair, and tendon repair. Orthocell also specializes in advanced cellular therapies, notably Ortho-ATI (Autologous Tenocyte Implantation) for treating chronic tendon injuries and Ortho-ACI (Autologous Chondrocyte Implantation) for cartilage repair. These therapies utilize a patient's own cells to restore function and structure to damaged tissues. The company aims to provide restorative solutions that improve clinical outcomes and offer alternatives to traditional surgical interventions.

Recent filings

Filing Released Lang Actions
Notification regarding unquoted securities - OCC 7 pages 30.4KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Notification of Issue, Conversion or Payment up of Unquoted Equity Securities' and details the issuance of unquoted options by Orthocell Limited. It includes specifics such as the number of securities issued, the nature of the securities (unquoted options), the issue date, and the consideration (provision of consultancy services). The document is an announcement of a securities issuance event rather than a financial report or regulatory filing about financial results or governance. It does not contain financial statements or management discussion but focuses on capital structure changes related to securities issuance. Therefore, it fits the category of 'Share Issue/Capital Change' (SHA). The document length (7097 characters) and content confirm it is a full announcement, not just a brief notice or report publication announcement.
2021-10-25 English
Application for quotation of securities - OCC 6 pages 25.5KB
Share Issue/Capital Change Classification · 100% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary fully paid shares. It includes specifics about the number of securities, issue dates, and classifications. This type of document is related to capital changes and securities issuance rather than financial results, management changes, or regulatory certifications. It is not a report or announcement of financial performance but a formal notice of securities to be quoted. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is not a brief announcement but a detailed application form.
2021-10-17 English
Notice under Section 708(A) of the Corporations Act 2 pages 153.0KB
Capital/Financing Update Classification · 95% confidence The document is a notice under Section 708A(5)(e) of the Corporations Act, which relates to the issuance of securities without disclosure under Part 6D.2 of the Corporations Act. It provides details about the securities issued, including class, ASX code, date, and number of shares issued. The document is short (3162 characters) and serves as a formal announcement to the ASX and investors about the share issuance and compliance with disclosure requirements. It does not contain financial statements or detailed financial analysis, nor is it a report or presentation. This type of document fits the category of Capital/Financing Update (CAP), as it relates to company fundraising and capital structure changes through the issuance of shares.
2021-10-17 English
Change of Director's Interest Notices 8 pages 420.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Change of Director’s Interest Notices' and includes detailed disclosures about share sales by company directors, specifically Dr Stewart Washer and Mr Paul Anderson. It references Appendix 3Y, which is a standard ASX form for notifying changes in directors' interests in securities. The content includes specifics on the number of shares disposed, consideration received, and the nature of the transactions (on-market trades). There is no financial performance data, earnings information, or management discussion. The document is clearly a regulatory disclosure about insider share transactions by directors, fitting the definition of Director's Dealing filings.
2021-09-23 English
Notice of Annual General Meeting/Proxy Form 18 pages 795.7KB
AGM Information Classification · 100% confidence The document is titled 'Notice of Annual General Meeting and Explanatory Memorandum to Shareholders' for Orthocell Limited. It includes details about the AGM date, location, agenda items such as receiving the financial report, adopting the remuneration report, re-election of a director, approval of placement capacity, and renewal of takeover provisions. It also contains proxy voting instructions and explanatory notes for shareholders. The document is clearly a notice and explanatory memorandum related to the Annual General Meeting, not the actual annual report or financial statements themselves. It is a presentation of materials shared for the AGM, consistent with the definition of AGM Information (AGM-R). The document length (15,000 characters) and content confirm it is not a brief announcement or a certification but a full AGM notice and explanatory memorandum.
2021-09-20 English
Letter to Shareholders - Annual General Meeting 1 p
AGM Information Classification · 100% confidence The document is a notice to shareholders about the upcoming Annual General Meeting (AGM) of Orthocell Limited, including details about the meeting date, location, proxy voting instructions, and how to access the Notice of Meeting. It explicitly states it is the 'Annual General Meeting – Notice and Proxy Form' and provides instructions related to the AGM. The document does not contain financial statements or detailed financial performance data, nor is it a transcript or report of the meeting itself. It is a communication related to the AGM, specifically the notice and proxy form. Therefore, it fits the category of AGM Information (AGM-R). The document length is relatively short and it is not an announcement of a report publication but the actual notice and proxy form for the AGM.
2021-09-20 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.